Sfoglia per Autore
Measurable residual disease–dependent unfavorable outcomes in pediatric PAX5-rearranged B-acute lymphoblastic leukemia
2026 Peccatori, N; Curto, A; Silvestri, D; Rebellato, S; Antic, Z; Nebral, K; Bergmann, A; Strehl, S; Zimmermann, M; Saitta, C; Palmi, C; Bardini, M; Bhatia, S; Borkhardt, A; Quadri, M; Guardo, D; Lo Nigro, L; Parasole, R; Putti, M; Locatelli, F; Alten, J; Stanulla, M; Buldini, B; Sarno, J; Davis, K; Conter, V; Balduzzi, A; Valsecchi, M; Biondi, A; Attarbaschi, A; Schrappe, M; Cario, G; Rizzari, C; Cazzaniga, G; Fazio, G
Germline and somatic cohesin genes alterations in pediatric acute lymphoblastic leukemia
2026 Gaspari, D; Rebellato, S; Rigotti, L; Lettieri, A; Castiglioni, S; Saitta, C; Bettini, L; Silvestri, D; Mariani, M; Totaro, S; Spinelli, O; Pastorczak, A; Brandes, D; Fischer, U; Borkhardt, A; Strehl, S; Lo Nigro, L; Buldini, B; Hauer, J; Auer, F; Kester, L; Kuiper, R; Vinti, L; Locatelli, F; Gervasini, C; Massa, V; Selicorni, A; Fazio, G; Cazzaniga, G
INTERIM RESULTS OF THE QUESTIONNAIRE ON PREDISPOSITION TO ACUTE LYMPHOBLASTIC LEUKEMIA IN THE AIEOP-BFM ALL 2017 PROTOCOL
2026 Bettini, L; Lattuada, M; Silvestri, D; Lo Nigro, L; Bertorello, N; Parasole, R; Putti, M; Locatelli, F; Conter, V; Valsecchi, M; Biondi, A; Rizzari, C; Cazzaniga, G
Is creatine kinase a valid aid in early cardiac muscle damage detection during treatment for childhood acute lymphoblastic leukemia? A case report
2026 Fazio, G; Intra, J; Montini, O; Bettini, L; Gotti, G; Sala, A; Bungaro, S; Cazzaniga, G; Rizzari, C; Balduzzi, A; Casati, M
Challenges in identifying paediatric cancer predisposition syndromes: international SCOPE survey and SIOPE expert consensus recommendations
2026 Cavar Pavic, J; Cullinan, N; Jongmans, M; Bourdeaut, F; Wadt, K; Lonigro, L; Davies, M; Michaeli, O; Strang-Karlsson, S; De Putter, R; Sepulchre, E; Cazzaniga, G; Furtwangler, R; Zweier, C; Rossler, J; Waespe, N
Targeting oncogene-induced senescence in ETV6::RUNX1 pre-leukemic cells
2026 Acunzo, D; Bertagna, M; Risca, G; Beneforti, L; Bresolin, S; Galimberti, S; Sanchez-Garcia, I; Biondi, A; Cazzaniga, G; Palmi, C
Integrated characterization of EGFR amplification architecture and EGFRvIII status in patient-derived glioblastoma stem cells
2026 Ghizzi, M; Sinoni, E; Redaelli, S; Sirtori, A; Ramazzotti, D; Cazzaniga, G; Bentivegna, A
PEDIATRIC PAX5-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IS A HIGH-RISK MOLECULAR SUBGROUP OF B-ALL WITH A POOR MRD-DEPENDENT PROGNOSTIC PROFILE
2026 Peccatori, N; Curto, A; Silvestri, D; Rebellato, S; Antic, Z; Bhatia, S; Bergmann, A; Borkhardt, A; Zimmermann, M; Strehl, S; Nebral, K; Saitta, C; Quadri, M; Palmi, C; Bardini, M; Guardo, D; Lo Nigro, L; Parasole, R; Putti, M; Locatelli, F; Alten, J; Stanulla, M; Valsecchi, M; Buldini, B; Conter, V; Biondi, A; Balduzzi, A; Schrappe, M; Attarbaschi, A; Cario, G; Rizzari, C; Cazzaniga, G; Fazio, G
clinTALL: machine learning-driven multimodal subtype classification and treatment outcome prediction in pediatric T-ALL
2026 Stoiber, L; Antic, Z; Rebellato, S; Fazio, G; Rademacher, A; Lenk, L; Locatelli, F; Balduzzi, A; Cario, G; Rizzari, C; Cazzaniga, G; Yu, J; Bergmann, A
TARGETING ONCOGENE-INDUCED SENESCENCE IN ETV6::RUNX1 PRE-LEUKEMIC CELLS
2026 Acunzo, D; Bertagna, M; Risca, G; Beneforti, L; Bresolin, S; Galimberti, S; Sanchez-Garcia, I; Biondi, A; Cazzaniga, G; Palmi, C
FLT3 AS A NEW THERAPEUTIC TARGET IN PRECLINICAL MODELS OF PEDIATRIC BCP-ALL WITH PAX5 REARRANGEMENT
2026 Curto, A; Peccatori, N; Rebellato, S; Rapisarda, R; Bhatia, S; Borkhardt, A; Palmi, C; Bardini, M; Biondi, A; Cazzaniga, G; Fazio, G
A novel highly recurrent fusion circRNA from the kmt2a::aff1 fusion gene impacting mitochondrial metabolism in B-ALL with the t(4;11)(q21.3-q22.1;q23.3) translocation
2026 Tolomeo, D; Bardini, M; Venuto, S; Visci, G; Lonoce, A; Calamo, L; Cifola, I; Severgnini, M; Mastrodonato, M; Semeraro, D; Valsecchi, L; Mauri, M; La Starza, R; Lucarelli, M; Azzariti, A; Serrati, S; Ferrari, A; Martinelli, G; Santoro, N; Fumagalli, M; Cazzaniga, G; Fazio, G; Storlazzi, C
Cytopenia, Hypocellular Bone Marrow, and Shortened Telomere Length Beyond Biallelic Telomere Biology Gene Mutations
2026 Franco, G; Bruno, L; Alviano, A; Vankann, L; Brümmendorf, T; Guerra, F; Vendemini, F; Faverio, P; L’Imperio, V; Cazzaniga, G; Luppi, F; Biondi, A; Balduzzi, A; Beier, F; Saettini, F
A multi-dimensional approach to recognize genetic predisposition in children with acute lymphoblastic leukemia
2025 Junk, S; Bettini, L; Daugs, K; Mescher, M; Jongmans, M; Borkhardt, A; Cazzaniga, G; Kuiper, R; Bakhuizen, J
Overt and covert genetic causes of pediatric acute lymphoblastic leukemia: ACUTE LYMPHOBLASTIC LEUKEMIA
2025 Stoltze, U; Junk, S; Byrjalsen, A; Cave, H; Cazzaniga, G; Elitzur, S; Fronkova, E; Hjalgrim, L; Kuiper, R; Lundgren, L; Mescher, M; Mikkelsen, T; Pastorczak, A; Strullu, M; Trka, J; Wadt, K; Izraeli, S; Borkhardt, A; Schmiegelow, K
A novel RTEL1 nonsense variant in a case of familial pulmonary fibrosis: clinical description and genetic implications
2025 Franco, G; Bertola, F; Aloisi, F; Promi, S; Zanini, U; Faverio, P; Bentivegna, A; Borie, R; Crestani, B; Cazzaniga, G; Luppi, F
Exploring glioblastoma heterogeneity: the impact of ecDNA on tumor evolution and progression
2025 Ghizzi, M; Sirtori, A; Ripamonti, G; Sala, C; Gautiero, E; Sala, E; Redaelli, S; Cazzaniga, G; Bentivegna, A
First-Tier Versus Last-Tier Trio Whole-Genome Sequencing for the Diagnosis of Pediatric-Onset Rare Diseases
2025 Lucca, C; Rosina, E; Pezzani, L; Piazzolla, D; Spaccini, L; Scatigno, A; Gasperini, S; Pezzoli, L; Cereda, A; Milani, D; Cattaneo, E; Cavallari, U; Frigeni, M; Marchetti, D; Daolio, C; Giordano, L; Bellini, M; Goisis, L; Mongodi, C; Tonduti, D; Pilotta, A; Cazzaniga, G; Furlan, F; Bedeschi, M; Mangili, G; Bonanomi, E; Iascone, M
Cohesins: Crossroad Between Cornelia de Lange Spectrum and Cancer Predisposition
2025 Rigotti, L; Rebellato, S; Lettieri, A; Castiglioni, S; Mariani, M; Totaro, S; Saitta, C; Gervasini, C; Fazio, G; Massa, V; Cazzaniga, G; Selicorni, A
PAX5::AUTS2 childhood B-ALL: a relapse-prone genetic subtype with frequent central nervous system involvement and a poor outcome: ACUTE LYMPHOBLASTIC LEUKEMIA
2025 Caye-Eude, A; Fazio, G; Pastorczak, A; Boer, J; Steinemann, D; Ganguli, D; Sonneveld, E; Haslinger, S; D'Andrea, L; Bradtke, J; Lopes, B; Zaliova, M; Escherich, G; König, M; Fortschegger, K; Inthal, A; Stasevich, I; Emerenciano, M; Trka, J; Castillo, L; Parihar, M; Moorman, A; Bergmann, A; den Boer, M; Młynarski, W; Cazzaniga, G; Cavé, H; Nebral, K; Schinnerl, D; Strehl, S
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile